Growth trajectory Devana Solutions is a SaaS provider with a current revenue range of 1M to 10M and a team size of 11-50, indicating a small-to-mid-sized company in a growth phase. This suggests potential upsell opportunities for expanded licenses, additional modules, or premium support as client base matures.

Strategic acquisitions Recent news shows RealTime eClinical Solutions acquiring Devana Solutions along with Complion, signaling consolidation in the clinical trials tech space. This indicates an opportunity to engage sponsors and CROs already benefiting from RealTime’s expanded platform ecosystem for cross-sell and integration partnerships.

Platform fit PROPEL is designed for real-time data capture and transparency across sites to CROs and sponsors, targeting drug development stakeholders. Sales conversations can emphasize data empowerment, workflow automation, and interoperability as differentiators to sponsors seeking efficiency and cost reduction.

Customer reach Past leadership hires in UX, Product, and Customer Success and a focus on strategic partnerships imply a growing customer success and adoption mentality. This creates an opening for value-based renewal discussions, expanded use cases, and referrals within the clinical research community.

Industry positioning The company operates in a competitive niche with notable peers and acknowledges partnerships with non-profits like Greater Gift, highlighting a potential angle for ESG and patient-centric storytelling. Sales can leverage this to approach sponsors prioritizing ethical, patient-focused clinical operations and collaborations.